Trader consensus on Polymarket reflects a 71% implied probability that Sam Altman will not receive formal equity in OpenAI by June 30, driven primarily by the high-stakes ongoing trial with Elon Musk, now in its second week as of April 30. Musk's testimony highlighted OpenAI's 2025 restructuring from nonprofit to for-profit public benefit corporation—allegedly breaching founding charters—while emphasizing Altman's zero current equity stake despite the firm's $852 billion valuation and record $110 billion-plus fundraises. Governance concerns persist amid reports of Altman's pushes for OpenAI investments in his personal ventures like Helion Energy, fueling board and investor skepticism. With trial resolution uncertain before the deadline and CFO Sarah Friar questioning aggressive 2026 IPO timelines, traders anticipate legal hurdles delaying any equity grant, though a favorable ruling could swiftly shift dynamics in this pivotal AI lab leadership saga.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
Sí
Taking equity is defined as Sam Altman acquiring or being granted shares, stock options, or any other form of ownership interest in OpenAI.
Any pre-existing interest held through Y Combinator's investment fund or other indirect holdings made prior to Altman becoming full-time at OpenAI will not count toward this market's resolution.
The resolution source for this market will be a consensus of credible reporting.
Mercado abierto: Nov 12, 2025, 5:14 PM ET
Resolver
0x65070BE91...Taking equity is defined as Sam Altman acquiring or being granted shares, stock options, or any other form of ownership interest in OpenAI.
Any pre-existing interest held through Y Combinator's investment fund or other indirect holdings made prior to Altman becoming full-time at OpenAI will not count toward this market's resolution.
The resolution source for this market will be a consensus of credible reporting.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects a 71% implied probability that Sam Altman will not receive formal equity in OpenAI by June 30, driven primarily by the high-stakes ongoing trial with Elon Musk, now in its second week as of April 30. Musk's testimony highlighted OpenAI's 2025 restructuring from nonprofit to for-profit public benefit corporation—allegedly breaching founding charters—while emphasizing Altman's zero current equity stake despite the firm's $852 billion valuation and record $110 billion-plus fundraises. Governance concerns persist amid reports of Altman's pushes for OpenAI investments in his personal ventures like Helion Energy, fueling board and investor skepticism. With trial resolution uncertain before the deadline and CFO Sarah Friar questioning aggressive 2026 IPO timelines, traders anticipate legal hurdles delaying any equity grant, though a favorable ruling could swiftly shift dynamics in this pivotal AI lab leadership saga.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes